Oxaprozin versus diclofenac in the treatment of rheumatoid arthritis;Therapie der rheumatoiden arthritis mit nichtsteroidalen antiphlogistika: Oxaprozin versus diclofenac

Aktuelle Rheumatologie

Volumn 23, Issue 1, 1998, Pages 11-15

  Karbowski, A ^a   Schwitalle, M ^b   Eckardt, A ^b  

^a Krankenhaus der Augustinerinnen   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; OXAPROZIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG SCREENING; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; RANDOMIZED CONTROLLED TRIAL; RHEUMATOID ARTHRITIS; STATISTICAL ANALYSIS;

EID: 0031935221     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043572     Document Type: Article

References (38)

1. Al-Faks M. A., M. C. Pugh: Oxaprozin: a new NSAID, Orthop Rev 21 (1992) 558-563
2. American Rheumatology Association: Criteria for rheumatoid arthritis. J Rheumatol Suppl 8 (1982) 120-123
3. Australian Multicentre Clinical Trial Group: Sulfasalazine in early rheumatoid arthritis. J Rheumatol 19 (1992) 1672-1677
4. Bertin P. et al.: Sodium naproxen: concentration and effect on inflammatory response mediators in human rheumatoid synovial fluid. Eur J Clin Pharmacol 46 (1994) 3-7
5. Boumpas D. T., G. P. Chrousos, R. P Wilder, T. R. Cupps, J. E. Balow: Glucocorticoid therapy for immune-mediated diseases: Basic and clinical correlates. Ann Intern Med 119 (1993) 1198-1208
6. Brune K., W. S. Beck: Nichtopioidanalgetika (antipyretische Analgetika und andere). In: Zenz M., J. Jurna.: Lehrbuch der Schmerztherapie. Wiss Verlagsges Stuttgart 1993
7. Chiang S. T., G. Morrison, J. A. Knowles, H. W. Ruelius, B. R. Walker: Oxaprozin disposition in renal disease. Clin Pharmacol Ther 31 (1982) 509-515
8. Cummings D. M., P. Jr. Amadio: A review of selected newer nonsteroidal anti-inflammatory drugs [see comments]. Am Fam Physician 49 (1994) 1197-1202
9. Dayer J. M., H. Fenner: The role of cytokines and their inhibitors in arthritis. Baill Clin Rheumatol 6 (1992) 485-516
10. Dickson D. J.: Current Therapeutic Research, 49 (1991) 2
11. Engel J.-M., G. Ströbel: Rheumatherapie. VCH Edition medizin, Weinheim 1990
12. Eulert J., J. Eichler: Praktische Orthopädie, 34. Fortbildungstagung des Berufsverbandes der Ärzte für Orthopädie e.V., Thieme, Stuttgart 1995
13. Ginsberg F., J. P. Famaey: A double-blind, parallel trial of oxaprozin versus naproxen in the treatment of osteoarthritis. Curr Med Res Opin 8 (1984) 689-695
14. Grasedyck K,: Kombinationstherapie bei chronischer Polyarthritis. Z Rheumatol 54 (1995)
15. Hale V. G., E. D. Bashaw: Pharmacokinetics of oxaprozin [letter, comment]. Clin Pharm 12 (1993) 255-6
16. Hubsher J. P. et al.: Oxaprozin once and aspirin q.i.d. in the treatment of osteoarthrosis: a multicentre study. Clin Res 31 (1983) 629 A
17. Krüger K., M. Schattenkirchner: Pathogenetisch orientierte Therapieansätze in der Behandlung der chronischen Polyarthritis. Internist 30 (1989) 656-663
18. Krüger K.: Cyclosporin in der Therapie rheumatischer Krankheiten. Indikationen und Anwendungsprinzipien. Z Rheumatol 54 (im Druck)
19. Kurowski M., H. Thabe: The transsynovial distribution of oxaprozin. Agents Actions 27 (1989) 458-460
20. Lanza F. L., J. A. Hubsher, B. R. Walker: Gastroscopic evaluation of the effect of aspirin and oxaprozin on the gastric mucosa. J Clin Pharmacol 21 (1981) 157-161
21. Lucker P. W. et al.: Gastric irritation of oxaprozin, a new nonsteroidal, anti-inflammatory drug, in comparison to acetylsalicylic acid and indometacin: a gastric potential difference analysis. Methods. Find Exp Clin Pharmacol 9 (1987) 469-475
22. Lussier A., E. LeBel, L. Tetreault: Gastrointestinal blood loss of oxaprozin and aspirin with placebo control. J Clin Pharmacol 22 (1982) 173-178
23. Miller L. G.: Oxaprozin: a once-daily nonsteroidal anti-inflammatory drug [see comments]. Clin Pharm 11 (1992) 591-603
24. Mitnick P. D. et al.: Effects of two nonsteroidal anti-inflammatory drugs, indometacin and oxaprozin, on the kidney. Clin Pharmacol Ther 28 (1980) 680-689
25. Mohr, W.: Arthrosis deformans. In: Doerr W. et al.: Spezielle Pathologie, Band 18/1. Springer, Berlin 1984
26. Otterness I. G., M. L. Bliven, J. T. Downs, E. J. Natoli, D. C. Hanson: Inhibition of interleukin I synthesis by tenidap: a new drug for arthritis. Cytokine 3 (1991) 277-283
27. Oxaprozin for arthritis. Med Lett Drgs Ther 35 (1993) 15-16
28. Rainsford K. D.: Comparative irritancy of oxaprozin on the gastrointestinal tract of rats and mice: relationship to drug uptake and effects in vivo on eicosanoid metabolism. Aliment Pharmacol Ther 2 (1988) 439-450
29. Raspe H. H.: Chronische Polyarthritis. Komprehensive Versorgung. Therapiewoche 35 (1985) 2232-2236
30. Raspe H. H.: Memorandum der Deutschen Gesellschaft für Rheumatologie. Grundzüge einer wohnortnahen kontinuierlichen und kooperativen Versorgung von chronisch Rheumakranken in der Bundesrepublik Deutschland. Z. Rheumatol (1994) 113-134
31. Ritchie D. A., J. A. Boyle, J. M. Mclnnes, M. K. Jasani, T. G. Dalakos, P. Grieveson, W. W. Buchanan: Evaluation of a simple articular index for joint tenderness in rheumatoid arthritis. Ann Rheum Dis 28 (2) (1969) 196
32. Santo J. E., M. V. Queiroz: Oxaprozin versus diclofenac sodium in the treatment of ankylosing spondylitis. J Int Med Res 16 (1988) 150-156
33. Scott D. L.: The course and outcome of rheumatoid arthritis. Baill Clin Rheumatol 6/1 (1992)
34. Simon L. S.: Actions and toxic effects of the nonsteroidal antiinflammatory drugs. Curr Opin Rheumatol 6 (1994) 238-251
35. Todd P. A., R. N. Brogden: Oxaprozin. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs 32 (1986) 291-312
36. Williams H. J. et al.: Comparison of naproxen and acetaminophen in a two-year study of treatment of osteoarthritis of the knee [see comments]. Arthritis Rheum 36 (1993) 1196-1206
37. Wiliams K. M., R. O. Day, S. N. Breit: Biochemical actions and clinical pharmacology of anti-inflammatory drugs. Advanc Drug Res 24 (1993) 121-198
38. Winter L. Jr., A. Post: Double-blind comparison of single oral doses of oxaprozin, aspirin, and placebo for relief of post-operative oral surgery pain. J Int Med Res 11 (1983) 308-314